Specialty Laboratories Collaborates With Siemens and SEQUENOM on Molecular Diagnostics

08-Apr-2005

Specialty laboratories, Inc. will participate as a U.S. site for a joint working group on molecular diagnostics initiated by Sequenom, Inc. and Siemens Medical Solutions of Siemens AG. This collaboration combines the specialized assets and resources of the three organizations. Siemens Medical Solutions will contribute project funding and engineering expertise. Specialty Laboratories will contribute its expertise in clinical assay validation and workflow analysis. SEQUENOM will provide its MassARRAY Compact, consumables, technical support and analytically validated assays for specific diagnostic tests.

The partnership between Siemens and SEQUENOM was announced in late 2004 when the two companies stated they would work in concert with participating reference laboratories to execute a comprehensive functional requirement analysis for a molecular diagnostics platform.

The first phase of the joint program is a benchmarking study evaluating the analytical data quality and current workflow of the MassARRAY System in laboratories certified under Clinical Laboratory Improvement Amendments (CLIA). The three organizations expect the benchmarking study to be completed by the fourth quarter 2005.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures